Somatic and Germline Mutations
We investigate germline and somatic mutations that drive prostate cancer development and progression using genomic, computational, and molecular approaches.
Basic Science
Fields of study
Drug Repurposing & Therapeutic Discovery
Our lab identifies new therapeutic opportunities by repurposing existing drugs for urologic cancers. By integrating patient data, molecular biology, and experimental models, we evaluate how known compounds can be redirected to target cancer-specific pathways. This approach accelerates the translation of scientific discoveries into clinically actionable treatments.